Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy?
Authors: Samir Gupta
Journal: Annals of Internal Medicine (2009)

Letters3 March 2009Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy?Samir Gupta, MDSamir Gupta, MDFrom the University of Texas Southwestern Medical Center, Dallas, TX 75235.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-150-5-200903030-00019 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The demonstration that all screening strategies recommended by the U.S. Preventive Services Task Force (USPSTF) are nearly equivalent for prevention of colorectal cancer mortality (assuming 100% adherence) is the most interesting aspect of the analysis by Zauber and colleagues (1, 2). Differences in life-years gained between strategies for the MISCAN (Microsimulation Screening Analysis) model ranged from 227 to 230 life-years gained per 1000 persons, which is probably within the range of statistical error or small changes in model assumptions. In contrast, the differences in number of screening tests and volume of associated colonoscopy required between strategies differed ...References1. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:638-58. [PMID: 18838718] LinkGoogle Scholar2. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659-69. [PMID: 18838717] LinkGoogle Scholar3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al; American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58:130-60. [PMID: 18322143] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Samir Gupta, MDAffiliations: From the University of Texas Southwestern Medical Center, Dallas, TX 75235.Grant Support: By National Institutes of Health grant KL2RR024983.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoScreening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force Evelyn P. Whitlock , Jennifer S. Lin , Elizabeth Liles , Tracy L. Beil , and Rongwei Fu Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force Ann G. Zauber , Iris Lansdorp-Vogelaar , Amy B. Knudsen , Janneke Wilschut , Marjolein van Ballegooijen , and Karen M. Kuntz Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy? Ann G. Zauber , Marjolein van Ballegooijen , and Karen M. Kuntz Metrics Cited byPreferences for Colorectal Cancer Screening Techniques and Intention to Attend: a Multi-Criteria Decision AnalysisCost-effectiveness of colorectal cancer screening – An overview 3 March 2009Volume 150, Issue 5Page: 359KeywordsCancer preventionClinical trialsColonoscopyColorectal cancerColorectal cancer screeningConflicts of interestMortality ePublished: 3 March 2009 Issue Published: 3 March 2009 Copyright & PermissionsCopyright © 2009 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...